Formulations of bendamustine | Patent Number 08609707

US 08609707 B2
Application Number13016473
Publication NumberUS 20110184036 A1
Pendency2 years, 10 months, 24 days
Filled DateJan 28, 2011
Priority DateJan 28, 2010
Publication DateJul 28, 2011
Expiration DateJan 27, 2030
Inventor/ApplicantsPhilip Christopher Buxton
Nagesh R. Palepu
ExaminesAKHOON, KAUSER M
Art Unit1613
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.